Getty Images/Joern Pollex
- For $8,000, a startup called Ambrosia plans to sell transfusions of young blood for anti-aging purposes.
- Another longevity company called Alkahest is also focused on blood. But it's taking a very different approach.
- Instead of opening up a clinic to perform transfusions of young blood, Alkahest researchers aim to develop drugs for age-related diseases which are inspired by their work with plasma.
Blood gets a bad rap.
The idea of sharing blood with another person for anything other than a life-saving procedure makes a lot of people squeamish. That's probably why, shortly after word got out that a startup called Ambrosia aimed to sell transfusions of blood from young people to help older people fend off aging, people began to freak out.
See the rest of the story at Business Insider
NOW WATCH: I stopped eating breakfast for 2 weeks and I'm never doing it again
See Also:
- A top Silicon Valley VC firm avoided investing in prescription drugs for a decade. Here's why Andreessen Horowitz is changing its mind.
- A genetic testing company you've never heard of could become a household name as it takes on 23andMe
- A controversial startup that charges $8,000 to fill your veins with young blood now claims to be up and running in 5 cities across the US
DON'T MISS: We'll get you caught up on all the news you missed at the year's biggest healthcare investor conference
from Business Insider https://read.bi/2FCgziX
No comments:
Post a Comment